Literature DB >> 20659710

The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.

Yuan Gao1, Xia Wang, Jin Han, Zhifeng Xiao, Bing Chen, Guannan Su, Jianwu Dai.   

Abstract

OCT4 is one of the key transcription factors in maintaining the pluripotency and self-renewal of embryonic stem (ES) cells. Human OCT4 can generate two isoforms OCT4A and OCT4B by alternative splicing. OCT4B1 is a recently discovered novel OCT4 spliced variant, which has been considered as a putative marker of stemness. Compared with the OCT4B mRNA, OCT4B1 mRNA is generated by retaining intron 2 as a cryptic exon which contains a TGA stop codon in it. As a result, the protein product of OCT4B1 mRNA could be truncated. Interestingly, we present here that OCT4B1 can indirectly produce the same protein products as OCT4B. We have demonstrated that OCT4B1 mRNA can be spliced into OCT4B mRNA, and encode three protein isoforms. The splicing of OCT4B1 mRNA into OCT4B mRNA can be remarkably inhibited by the mutation of the classical splicing site. Our result suggests that OCT4B mRNA may originate from OCT4B1 mRNA by alternative splicing. Copyright 2010 Institute of Genetics and Developmental Biology and the Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659710     DOI: 10.1016/S1673-8527(09)60065-5

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  16 in total

1.  Prognostication of OCT4 isoform expression in prostate cancer.

Authors:  Marina França de Resende; Ludmilla Thomé Domingos Chinen; Samantha Vieira; Juliano Jampietro; Francisco Paulo da Fonseca; José Vassallo; Luciene Cristina Campos; Gustavo Cardoso Guimarães; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  Tumour Biol       Date:  2013-05-01

2.  OCT4B mediates hypoxia-induced cancer dissemination.

Authors:  Sheng-Chieh Lin; Chi-Hsiu Chung; Chih-Hung Chung; Ming-Han Kuo; Cheng-Han Hsieh; Yu-Fan Chiu; Yi-Shing Shieh; Yu-Ting Chou; Cheng-Wen Wu
Journal:  Oncogene       Date:  2018-09-12       Impact factor: 9.867

3.  Alternative splicing in self-renewal of embryonic stem cells.

Authors:  Clara Y Cheong; Thomas Lufkin
Journal:  Stem Cells Int       Date:  2011-06-09       Impact factor: 5.443

4.  Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.

Authors:  M A Rijlaarsdam; H A D M van Herk; A J M Gillis; H Stoop; G Jenster; J Martens; G J L H van Leenders; W Dinjens; A M Hoogland; M Timmermans; L H J Looijenga
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

Review 5.  Pluripotency transcription factors and cancer stem cells: small genes make a big difference.

Authors:  Anfei Liu; Xiya Yu; Shanrong Liu
Journal:  Chin J Cancer       Date:  2013-02-19

6.  The differential expression of OCT4 isoforms in cervical carcinoma.

Authors:  Shao-Wen Li; Xiao-Ling Wu; Chun-Li Dong; Xiu-Ying Xie; Jin-Fang Wu; Xin Zhang
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.

Authors:  Christina Lönnroth; Marianne Andersson; Annika G Asting; Svante Nordgren; Kent Lundholm
Journal:  Int J Oncol       Date:  2014-09-30       Impact factor: 5.650

Review 8.  Role of Oct4 in the early embryo development.

Authors:  Guangming Wu; Hans R Schöler
Journal:  Cell Regen (Lond)       Date:  2014-04-29

9.  Oct4B, CD90, and CD73 are upregulated in bladder tissue following electro-resection of the bladder.

Authors:  Takumi Takeuchi; Akiko Tonooka; Yumiko Okuno; Mami Hattori-Kato; Koji Mikami
Journal:  J Stem Cells Regen Med       Date:  2016-05-30

Review 10.  An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.

Authors:  Majid Mehravar; Fatemeh Ghaemimanesh; Ensieh M Poursani
Journal:  Stem Cell Rev Rep       Date:  2021-01-02       Impact factor: 6.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.